1National Institute of Immunology, New Delhi, India.
The first human trials for a birth control vaccine targeting human chorionic gonadotrophin show promising efficacy. This development in contraceptive immunogens offers a new avenue for fertility control.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: